133 related articles for article (PubMed ID: 793999)
1. [First experiences with BS 100-141, a new antihypertensive substance].
Esch I
Int J Clin Pharmacol Biopharm; 1976 Sep; 14(2):109-12. PubMed ID: 793999
[TBL] [Abstract][Full Text] [Related]
2. Low dose guanfacine and methyldopa in mild essential hypertension. A multiple centre study.
Viskoper RJ; Laszt A; Paran E; Ben Ari J; Goren Y; Modan M
Neth J Med; 1987 Aug; 31(1-2):58-65. PubMed ID: 3309693
[No Abstract] [Full Text] [Related]
3. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.
Malini PL; Strocchi E; Ambrosioni E; Magnani B
Int J Clin Pharmacol Res; 1983; 3(1):35-9. PubMed ID: 6384071
[TBL] [Abstract][Full Text] [Related]
4. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension.
Farooki MS; Farsky K; Bouchard S; Lalonde Y; Brookman S
Clin Ther; 1985; 7(2):199-204. PubMed ID: 3886142
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of a new alpha-adrenoceptor agonist, guanfacine and alpha-methyldopa in the treatment of hypertension.
Joshi RC; De A; Cameron EG
Br J Clin Pract; 1984 Feb; 38(2):66-7, 71. PubMed ID: 6142723
[No Abstract] [Full Text] [Related]
6. A new centrally action antihypertensive agent guanfacine (BS 100-141).
Dubach UC; Huwyler R; Radielovic P; Singeisen M
Arzneimittelforschung; 1977; 27(3):674-6. PubMed ID: 326262
[TBL] [Abstract][Full Text] [Related]
7. [Guanfacine versus alpha-methyldopa in benign essential hypertension. An ambulatory group study].
Rhomberg F; Widler J
Schweiz Med Wochenschr; 1981 Dec; 111(50):1967-8. PubMed ID: 7036334
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive effect of N-amidino-2-(2,6-dichlorophenyl) acetamide hydrochloride. A double-blind cross-over trial versus clonidine.
Kirch W; Distler A
Int J Clin Pharmacol Biopharm; 1978 Mar; 16(3):132-5. PubMed ID: 348614
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of arterial hypertension with a single daily dose of guanfacine].
Jardim PC; Rassi S; Lopes M; Simioni PR; Guimarães E; Maranhão MF; Porto CC
Arq Bras Cardiol; 1984 Nov; 43(5):365-9. PubMed ID: 6399438
[No Abstract] [Full Text] [Related]
10. [A new antihypertensive agent used in a clinical setting].
Wetzels E; Raschig A; Kaiser HJ
Med Klin; 1980 Sep; 75(19):688-92. PubMed ID: 7001207
[TBL] [Abstract][Full Text] [Related]
11. [Guanfacine (Estulic) in the monotherapy of essential hypertension, grades I and II, according to WHO].
Mayer K; Lupínek Z; Janousek S; Podrouzková B
Cas Lek Cesk; 1984 Oct; 123(43):1306-11. PubMed ID: 6391673
[No Abstract] [Full Text] [Related]
12. [Double-blind assay of a new hypotensive agent of central action, guanfacine, compared with alpha-methyldopa].
Jiménez Casado M; Canto J; Yapur H; Oller JM
Rev Clin Esp; 1984 Jul 15-31; 174(1-2):41-4. PubMed ID: 6393236
[No Abstract] [Full Text] [Related]
13. [Clinical trial of a new antihypertensive preparation: guanfacine].
Rengo F; Ricciardelli B; Spirito G; Volpe M; Morrone G; Trimarco B; Condorelli M
Boll Soc Ital Cardiol; 1979; 24(10):1097-102. PubMed ID: 400394
[No Abstract] [Full Text] [Related]
14. Improved exercise performance of hypertensive patients treated with guanfacine (Estulic Sandoz).
Bazika V
Cor Vasa; 1987; 29(4 Suppl 1):42-5. PubMed ID: 3315450
[TBL] [Abstract][Full Text] [Related]
15. [Antihypertensive therapy with guanfacine. A multicenter study with Estulic-Wander 1mg. Determinants of effectiveness and tolerance].
Schäfer N; Knaup G
Med Welt; 1983 Feb; 34(5):158-61. PubMed ID: 6341756
[No Abstract] [Full Text] [Related]
16. [Blood pressure and renin under treatment of hypertension with guanfacine (author's transl)].
Rosenthal J; Jäger H
MMW Munch Med Wochenschr; 1980 Jan; 122(4):137-40. PubMed ID: 6767938
[TBL] [Abstract][Full Text] [Related]
17. Guanfacine: a new centrally-acting antihypertensive agent.
Beevers DG; Bloxham CA; Walker JM
Pharmatherapeutica; 1981; 2(8):513-6. PubMed ID: 7019931
[TBL] [Abstract][Full Text] [Related]
18. Non-invasive monitoring of ambulatory blood pressure and its variability in elderly hypertensive patients: effect of guanfacine.
Dupont AG; Vanderniepen P; Six RO
Bibl Cardiol; 1987; (42):161-7. PubMed ID: 3307757
[No Abstract] [Full Text] [Related]
19. Guanfacine in the treatment of hypertensives with a pronounced response to exercise and diabetes mellitus.
Dvorák I; Podrouzková B; Kocourková J; Kubesová H; Spác J; Nĕmcová H; Blaha M
Cor Vasa; 1987; 29(4 Suppl 1):30-6. PubMed ID: 3315448
[TBL] [Abstract][Full Text] [Related]
20. Long-term antihypertensive therapy with guanfacine.
Szám I; Holló J
Int J Clin Pharmacol Ther Toxicol; 1982 Aug; 20(8):388-92. PubMed ID: 6749702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
